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Summary.-Ethylene oxide and 1,2-propylene oxide were each administered intra-
gastrically by gavage at 2 dosages (30 and 7-5 mg/kg body wt; 60 and 15 mg/kg
body wt respectively) to groups of50 female Sprague-Dawley rats twice weekly for a
period of nearly 3 years using salad oil as the solvent. Both compounds induced local
tumours, mainly squamous-cell carcinomas of the forestomach, dependent on the
dosage. The first tumour occurred in the 79th week both in the group treated with
ethylene oxide and in that treated with 1,2-propylene oxide. The following tumour
rates resulted: ethylene oxide62 and 16%; 1,2-propylene oxide40 and 4%. In addition
carcinomata in situ, papillomas and reactive changes of the squamous epithelium
of the forestomach were observed in other animals, but neither ethylene oxide nor
1,2-propylene oxide induced tumours at sites away from the point of administration.
THE PRESENT ANNUAL CONSUMPTION of
ethylene oxide in Western Europe stands
at around 2-5 million tonnes (Schonfeldt,
1976), of which most is used in the
production ofvarious organic compounds.
Ethylene oxide is also used for the
fumigation offood and sterilization in the
field of medicine. The carcinogenic risk is
of particular importance in man. Indica-
tions of possible carcinogenic activity of
ethylene oxide arise primarily from the
mutagenic efficiency which has been
proven by various methods oftesting (see
review by Glaser, 1979; Wolman, 1979;
Ehrenberg & Hussain, 1981). Teratogenic
effects could also be induced by ethylene
oxide (La Borde & Kimmel, 1981). The
alkylation of DNA and RNA or the
mononucleotides by ethylene oxide and
1,2-propylene oxide has been investigated
by Lawley & Wallick (1957), Fraenkel-
Conrat (1961), Windmueller & Kaplan
(1961), Lawley & Jarman (1972) and
Ehrenberg et at. (1974). Further evidence
of carcinogenic activity of ethylene oxide
was provided by Reyniers et al. (1964) who
observed, in an uncontrolled study, a
higherincidence oftumours in female mice
after the unintentional use of bedding
which had been sterilized by ethylene
oxide. Hogstedt et al. (1978, 1979a, b)
reported an incidence oftumours in people
whose occupation involved exposure to
ethylene oxide. Carcinogenic activity of
1,2-propylene oxide upon s.c. administra-
tion to rats (Walpole, 1958) and mice
(Dunkelberg, 1979, 1981) has been demon-
strated, and ethylene oxide also showed a
weak carcinogenic effect after s.c. applica-
tion (Dunkelberg, 1979, 1981).
The aim of the experiment described
here was to test ethylene oxide and 1,2-
propylene oxide for carcinogenic activity
by intragastric administration to rats.
MATERIALS AND METHODS
Purity of test substances.-According to the
producer's data (J.T. Baker Chemicals BV,
Deventer, Netherlands) the ethylene oxide
was 99.7% pure and the 1,2-propylene oxide
(Merck-Schuchardt AG, Miinchen, Germany)
99% pure. The test substances as well asCARCINOGENICITY OF ETHYLENE OXIDE AND 1,2-PROPYLENE OXIDE
the solvent Livio oil (Union Deutscher
Lebensmittelwerke, Hamburg,Germany) were
first tested for impurities of polycyclic
aromatic hydrocarbons according to a
procedure described by Druckrey et al.
(1966). There was no evidence of such im-
purity. We recorded in addition the infra-red
spectra of the test substances and examined
them for agreement with the reference
spectra. Discrepancies which indicated im-
purities could not be established. The purity
of the substances was additionally checked
by gas chromatography.
Experimental groups
The experiment was performed on specifically
pathogen-free female Sprague-Dawley rats
(Ivanovas, Kisslegg, Germany), which were
about 100 days old at the beginning of the
experiment. They were confined in Macrolon
cages type III with a cover of stainless steel
wire. Sawdust was used as bedding. The rats
were fed with pellets ofthe Altrominstandard
diet no. 1313 (Altromin GmbH, Lage,
Germany) and tap water contained in
Macrolon bottles.
The test substances, ethylene oxide and
1,2-propylene oxide, were each administered
to groups of 50 rats per dosage. Two dosages
of both compounds were tested. A group of
50 rats was treated with the solvent oil
alone and another was left untreated.
As a positive control a group was treated with
fi-propiolactone.
Theanimals wereconfinedinair-conditioned
rooms, and the group treated with /-pro-
piolactone was situated in a room separate
from the other groups. The substances were
administered intragastrically twice weekly
to rats with empty stomachs. Accordingly
the food was removed from the cages about
16-18 h before the treatment. The test
substances were dissolved in oil immediately
before the treatment, so that the single
dose according to the average weight was
contained in 1 ml (Table I). Because of the
low boiling-point of ethylene oxide, 1,2-
propylene oxide and /-propiolactone the
solutions were kept in cooled containers.
fl-Propiolactone, scarcely soluble in oil,
was administered as a suspension. The test
substances were stored and the solutions
prepared in a laboratory away from the cages.
The administration took place with sterile
disposable syringes with stomach tubes
of 1-5 mm x 80 mm. The animals were
treated and observed for their lifespan and
were examined thoroughly at necropsy.
Pathologically noteworthy organs were re-
moved and fixed in 5% buffered formalin.
The stomach and the adjoining part of
duodenum were opened along the greater
curvature and, if change in the epithelium
could be observed, pinned flat on a plate.
After fixation these preparations were cut
into 6 longitudinal strips and embedded.
Paraplast sections were stained with haema-
toxylin and eosin. The diagnoses were
confirmed histologically. Between the 79th
and 82nd week several rats in the various
groups contracted pneumonia, during which
time the administrations were interrupted.
We treated all rats s.c. with 2 x 100 mg
chloramphenicol and subsequently added
tylosin-tartrate (Eli Lilly GmbH, Germany)
in a concentration of 0-5 g/l to the drinking
water over a period of 3 weeks. The experi-
ment lasted 150 weeks during which time
the ethylene oxide groups received the test
substances 214 times, the 1,2-propylene
oxide groups 219 times and the P-propio-
lactone group 100 times. The average total
dosage in mg/kg body wt for the various
groups is recorded in Table I.
RESULTS
The survival rates of the rats treated
with ethylene oxide and 1,2-propylene
oxide are comparable to those of the
control groups with the exception of
those treated with the higher dose of
ethylene oxide. The latter died earlier
from tumours. The survival rate of rats
treated with fl-propiolactone fell distinctly
as tumours started to develop (see Figs
1 & 2).
The first animal to develop a squamous-
cell carcinoma of the forestomach (Fig. 3)
was observed after 32 weeks of the
experiment in the ,B-propiolactone group.
Between the 52nd and 84th week the
majority of the animals in this group died
ofa carcinoma ofthe stomach. In total the
100 intragastric administrations of ,B-
propiolactone led to stomach tumours in
46/50 rats. In most ofthe cases mesenteric
metastases and metastases to the dia-
phragm as well as infiltration into the liver
were observed. Animals with stomach
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TABLE I.-Experimental groups for carcinogenicity testing of ethylene oxide and 1,2-
propylene oxide by intragastric administration to Sprague-Dawley rats
Group
Ethylene oxide I
Ethylene oxide II
1,2-Propylene oxide I
1,2-Propylene oxide II
Oil (vehicle)
Untreated
,-Propiolactone
50 ~ -.._
40 -
30-
20-
10 -
0
Single Average total No. of
dose (mg/kg body wt) dose (mg/kg body wt) animals
30 0 5112 50
7*5 1186 50
60v0 10798 50
15-0 2714 50
1 0m1 - 50
50
30*0 2868 50
without treatment
50 100 150 weeks
FIG. 1.-Length of survival of the rats treated with ethylene oxide.
tumours were also observed in the groups-
which were administered ethylene oxide
and 1,2-propylene oxide but not in those
which were administered only the oil or
left untreated. (Incidences andhistological
findings of the tumours are illustrated in
Figs 7 and 8). In most cases the stomach
tumours were squamous-cell carcinomas of
the forestomach. However, we observed
tumours of the glandular stomach in
animals treated with either compound.
One of these (a fibrosarcoma) occurred
in a rat treated with the higher
dose of ethylene oxide and it infiltrated
the liver and mesentery. In another
animal a pyloric adenocarcinoma was
present in addition to a squamous-cell
carcinoma. In the 1,2-propylene oxide I
group one animal had an adenocarcinoma
of the pylorus. The first tumour was
observed in the 79th week in both the
ethylene oxide I and in the 1,2-propylene
oxide I groups. We also observed car-
cinomata in situ (Fig. 4), early carcinomas
(Fig. 5) and reactive changes of the
squamous epithelium of the stomach such
as hyperkeratosis, hyperplasia andpapillo-
mas in some of the rats which were
administered ethylene oxide or 1,2-propy-
lene oxide and which died primarily of
another cause. (The corresponding fre-
quencies can be seen from Figs 7 and 8. In
the Figs each animal is classified once
only; if carcinoma and other findings (e.g.
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1,2-propylene oxide I
1,2-propylene oxide
..... .......... vehicle
without treatment
- /3 - propiolactone
50 100 150 weeks
FiG. 2.-Length of survival of the rats treated with 1,2-propylene oxide.
FIG. 3.-Squamous-cell carcinoma of the forestomach showing formation of horny pearls and invasive
growth in the glandular stomach (rat from the group treated with P-propiolactone). H. & E. x 55.
50-
40 -
30 -
20
10
0
927FiG. 4.-Carcinoma in situ of the forestomach in a rat from the ethylene oxide I group. H. & E. x 200.
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FIG. 5.-Early squamous-cell carcinoma ofthe forestomach (ethylene oxide I group) with onset ofinfiltrating
growth. H. & E. x 100.CARCINOGENICITY OF ETHYLENE OXIDE AND 1,2-PROPYLENE OXIDE
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FIG. 6.-Metastasis to a regional lymph node in a rat from the ethylene oxide I group with a squamous-cell
carcinioma of the forestomach. H. & E. x 200.
papilloma) occurred simultaneously in the
same animal, it was classified only under
the carcinoma group.)
As far as could be ascertained the
stomach tumours induced by /3-propiolac-
tone were the cause of death but tumours
in the mammary gland, pituitary and
uterus were the cause of death in some of
the rats treated with ethylene oxide and
1,2-propylene oxide (Table II). In other
rats the stomach tumours were the cause
of death. These rats comprised 15 animals
from the ethylene oxide I group which had
large stomach tumours, of which 10
revealed metastases (Fig. 6) and invasive
growth into neighbouring organs; and 4
animals treated with 1,2-propylene oxide I
which had 4 large tumours of which 2
showed infiltrative growth.
It can be seen from Figs 7 and 8 that
ethylene oxide and 1,2-propylene oxide
lead to the induction of the same type of
tumours. Despite a lower dosage (cf. Table
I) the number of animals with carcinomas
of the stomach in the ethylene oxide I
group is clearly greater than in the 1,2-
propylene oxide I group, and the rate of
reactive changes in the squamous epith-
elium of the stomach in the 1,2-propylene
oxide I group is correspondingly greater.
The frequencies of tumours away from
the route of administration in the groups
treated with ethylene oxide and 1,2-
propylene oxide and the control groups
can be seen in Table II. With regard to any
type of tumours occurring away from the
route ofapplication no clear increase could
be observed in the groups treated with
ethylene oxide and 1,2-propylene oxide in
comparison with controls.
DISCUSSION
Ourinvestigations clearly show that the
administration of ethylene oxide and 1,2-
propylene oxide by intragastric adminis-
929TABLE II.-Incidence of tumours occurring distantfrom the route ofadministration
Group
Ethylene oxide I
Site
Mammary gland
Uterus
Ethylene oxide II
1,2-Propylene oxide I
1,2-Propylene oxide II
Oil (vehicle)
Untreated
Intestine
Pituitary
Ovary
S.c. tissue
Lymphatic tissue
Nervous system
Mammary gland
Uterus
Ovary
Lymphatic tissue
Mammary gland
Uterus
Ovary
Vagina
Pituitary
Adrenal gland
Mammary gland
Uterus
Intestine
Adrenal gland
Lymphatic tissue
Mammary gland
Uterus
Kidney
Pituitary
Adrenal gland
Lymphatic tissue
Mammary gland
Uterus
Abdomen
Pituitary
Adrenal gland
Islets of Langerhans
Lymphatic tissue
Tumour (No. ofanimals)
Adenofibroma (1)
Fibroadenoma (8)
Fibroma (1)
Adenocarcinoma (2)
Sarcoma (2)
Mesenchymoma (1)
Leiomyoma (1)
Leiomyofibrosarcoma (3)
Malignant mesenchymoma (1)
Sarcoma (1)
Squamous-cell carcinoma (2)
Mesothelioma (1)
Adenoma (1)
Granulosa-theca cell tumour (1)
Mesenchymal tumour (1)
Malignant lymphoma (1)
Malignant schwannoma (1)
Adenofibroma (13)
Fibroadenoma (4)
Fibroma (1)
Adenocarcinoma (3)
Malignant mesenchymoma (1)
Leiomyofibrosarcoma (2)
Malignant granulosa-theca-cell
tumour (1)
Malignant lymphoma (3)
Adenofibroma (6)
Fibroadenoma (7)
Fibroma (2)
Adenocarcinoma (3)
Haemangioendothelioma (1)
Leiomyofibrosarcoma (1)
Granulosa-theca-cell tumour (1)
Squamous-cell carcinoma (1)
Adenoma (3)
Phaeochromocytoma (1)
Adenofibroma (7)
Fibroadenoma (3)
Fibroma (6)
Adenocarcinoma (2)
Adenocarcinoma (1)
Leiomyosarcoma (1)
Leiomyofibrosarcoma (1)
Adenocarcinoma (1)
Adenosarcoma (1)
Cortical adenocarcinoma (1)
Malignant Lymphoma (1)
Adenofibroma (4)
Fibroadenoma (7)
Fibroma (3)
Adenocarcinoma (1)
Leiomyofibrosarcoma (1)
Malignant nephroma (1)
Adenocarcinoma (1)
Phaeochromocytoma (1)
Malignant lymphoma (1)
Adenofibroma (1)
Fibroadenoma (5)
Fibroma (3)
Adenocarcinoma (1)
Malignant mesenchymoma (1)
Leiomyofibrosarcoma (1)
Fibroadenoma (1)
Schwannoma (1)
Adenocarcinoma (4)
Fibroma (1)
Adenoma (1)
Cortical adenocarcinoma (1)
Islet-cell carcinoma (1)
Malignant lymphoma (1)CARCINOGENICITY OF ETHYLENE OXIDE AND 1,2-PROPYLENE OXIDE
30 2 5 squamous cell carcinoma
E fibrosarcoma
B carcinoma in situ
W hyperkeratosis,
hyperplasia, papilloma
~20 E
0
E 10
z
ethylene oxide I ethylene oxide II
Group
F1G. 7.-Incidences of animals with stomaclh
tumours and reactive changes of the
squamous epithelium of the stomachl
amongst the rats administered ethylene
oxide.
tration induces malignant tumours in the
stomach ofthe rat. It is unlikely that these
tumours could have been caused by the
infection which appeared in our rats in the
course of the experiment or by the agents
employed in its treatment, despite the
claim that chloramphenicol might possess
carcinogenic activity (Schmahl, 1977;
IARC, 1978), since the control animals in
this experiment, as well as another 100
rats in another experiment did not develop
any stomach tumours, although they were
affected by the infection and treated in the
same way.
/-Propiolactone produced a high in-
cidence of stomach tumours in our experi-
ment. The incidence oftumours was higher
than that produced by ethylene oxide or
by 1,2-propylene oxide. Furthermore, the
tumours were generally larger than those
induced by either of the 2 test compounds
and were in all cases the primary cause of
death.
E 20-
Cu~ ~ ~ ru
'E-
0
E
z
1,2-propylene oxidel 1,2 -propyltene oxide II
Group
Fia. 8.-Incidences of animals with stomach
tumours and reactive changes of the
squamous epithelium of the stomach
amongst the rats administered 1,2-
propylene oxi(le.
Thus the carcinogenic effect of ,B-
propiolactone in our experiment is more
potent than that produced by ethylene
oxide or propylene oxide. /-Propiolactone
was investigated by Van Duuren et al.
(1966) via the intragastric route and was
also found to be a potent carcinogen.
These authors, however, failed to obtain
any positive results with the suspected
carcinogens d,l-diepoxybutane and glycid-
aldehyde. It is likely that the regimen of
treatment employed in our experiment
(viz., the twice weekly administration in-
stead of once weekly and the greater
number ofanimals) mayhave beenimport-
ant factors in enabling us to achieve a
positive result. Furthermore, the use of a
larger volume of solvent may have im-
proved the absorption of the test sub-
stance into the epithelium of the stomach.
The importance of the method of treat-
ment in carcinogenicity studies ofethylene
oxide by the oral route is demonstrated by
the negative results obtained when rodent
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food fumigated by a high concentration of
ethylene oxide was administered to rats
for the whole of their life-time. The slow
release of the compound from solid food
under the latter conditions may have
prevented a sufficient amount from pene-
trating the epithelium (Bar & Griepentrog,
1969).
In earlier experiments we were able to
show that the carcinogenic activity of
ethylene oxide and 1,2-propylene oxide
differ slightly from each other upon s.c.
application (Dunkelberg, 1979, 1981).
However, considerable differences become
evident upon intragastric administration,
when ethylene oxide is shown to be more
efficient than 1,2-propylene oxide. In the
case of the low pH value of the empty
stomach (pH - 1) the various acid-
catalysed hydrolysis of the 2 compounds
could considerably influence carcino-
genicity. According to Ehrenberg &
Hussain (1981) the estimated half-life of
ethylene oxide at pH 1 and 37°C is about
3*5 min and that of 1,2-propylene oxide
about 1 min. Ethylene oxide is therefore
somewhat more stable than 1,2-propylene
oxide under these conditions. Both com-
pounds are converted relatively quickly in
the acidic stomach juice. This is consistent
with the findings that ethylene oxide and
1,2-propylene oxide induced tumours
mainly in the forestomach and only rarely
in the glandular stomach. In contrast to
the forestomach the epithelium of the
glandular stomach is apparently less
exposed to attack bythe 2 test compounds
due to the protective influence of the
formation of juice pepsin-hydrochloric
acid. Because of the evidence of carcino-
genic activity of ethylene oxide new
aspects ofthe hygienic-toxicological evalu-
ation of this compound in relation to its
various areas of application such as the
chemical, pharmaceutical and food indus-
tries, as well as the medical sphere, must
be considered. The metabolic formation of
1,2-alkene epoxides from corresponding
alkenes must, however, also be taken into
account. It was established by Ehrenberg
et al. (1977) that male CBA mice which
were exposed to air contaminated with
[14C]-labelled ethene were able to meta-
bolize this olefine to ethylene oxide.
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